MAZE - Maze Therapeutics, Inc.

44.83
-0.470   -1.048%

Share volume: 383,490
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.17%

PREVIOUS CLOSE
CHG
CHG%
$45.30
-0.47
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2025 09-30-2025
Fiscal Quarter Q1 2025 Q3 2025
Report Date 05-14-2025 11-06-2025
Cash flow financing 127.378 M 143.757 M
Other financing cash flows -374.000 K 2.009 M
Cash flow 97.563 M 52.232 M
Net income -32.786 M -30.087 M
Depreciation 684.000 K 571.000 K
Changes in inventories 0.000 0.000
Changes in receivables 0.000 0.000
Investing Cashflow -299.000 K -66.883 M
Net Borrowings 0.000 0.000
Investing Activity Other 0.000 0.000
Dividends Paid 0.000 0.000
Exchange Rate Effect 0.000 0.000
Capital Expenditures 299.000 K 68.000 K
Cash Change 97.563 M 52.232 M